APA (7th ed.) Citation

Klausa, F., Świątoniowska-Lonc, N., Skotny, A., Mak, M. A., Wysokińska-Kordybach, A., Skiba, J., . . . Doroszko, A. (2026). Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review. Journal of Clinical Medicine, 15(11), 4113. https://doi.org/10.3390/jcm15114113

Chicago Style (17th ed.) Citation

Klausa, Filip, Natalia Świątoniowska-Lonc, Anna Skotny, Marek A. Mak, Agnieszka Wysokińska-Kordybach, Jacek Skiba, Krzysztof Ściborski, Waldemar Banasiak, and Adrian Doroszko. "Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review." Journal of Clinical Medicine 15, no. 11 (2026): 4113. https://doi.org/10.3390/jcm15114113.

MLA (9th ed.) Citation

Klausa, Filip, et al. "Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review." Journal of Clinical Medicine, vol. 15, no. 11, 2026, p. 4113, https://doi.org/10.3390/jcm15114113.